Cited 35 times in

Good Laboratory Standards for Clinical Next-Generation Sequencing Cancer Panel Tests

DC Field Value Language
dc.contributor.author심효섭-
dc.date.accessioned2018-07-20T07:51:02Z-
dc.date.available2018-07-20T07:51:02Z-
dc.date.issued2017-
dc.identifier.issn2383-7837-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/160590-
dc.description.abstractNext-generation sequencing (NGS) has recently emerged as an essential component of personalized cancer medicine due to its high throughput and low per-base cost. However, no sufficient guidelines for implementing NGS as a clinical molecular pathology test are established in Korea. To ensure clinical grade quality without inhibiting adoption of NGS, a taskforce team assembled by the Korean Society of Pathologists developed laboratory guidelines for NGS cancer panel testing procedures and requirements for clinical implementation of NGS. This consensus standard proposal consists of two parts: laboratory guidelines and requirements for clinical NGS laboratories. The laboratory guidelines part addressed several important issues across multistep NGS cancer panel tests including choice of gene panel and platform, sample handling, nucleic acid management, sample identity tracking, library preparation, sequencing, analysis and reporting. Requirements for clinical NGS tests were summarized in terms of documentation, validation, quality management, and other required written policies. Together with appropriate pathologist training and international laboratory standards, these laboratory standards would help molecular pathology laboratories to successfully implement NGS cancer panel tests in clinic. In this way, the oncology community would be able to help patients to benefit more from personalized cancer medicine.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherThe Korean Society of Pathologists-
dc.relation.isPartOfJOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.titleGood Laboratory Standards for Clinical Next-Generation Sequencing Cancer Panel Tests-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine-
dc.contributor.departmentDept. of Pathology-
dc.contributor.googleauthorJihun Kim-
dc.contributor.googleauthorWoong-Yang Park-
dc.contributor.googleauthorNayoung K. D. Kim-
dc.contributor.googleauthorSe Jin Jang-
dc.contributor.googleauthorSung-Min Chun-
dc.contributor.googleauthorChang-Ohk Sung-
dc.contributor.googleauthorJene Choi-
dc.contributor.googleauthorYoung-Hyeh Ko-
dc.contributor.googleauthorYoon-La Choi-
dc.contributor.googleauthorHyo Sup Shim-
dc.contributor.googleauthorJae-Kyung Won-
dc.contributor.googleauthorThe Molecular Pathology Study Group of Korean Society of Pathologists-
dc.identifier.doi10.4132/jptm.2017.03.14-
dc.contributor.localIdA02219-
dc.relation.journalcodeJ01680-
dc.identifier.eissn2383-7845-
dc.identifier.pmid28535585-
dc.subject.keywordHigh-throughput nucleotide sequencing-
dc.subject.keywordMolecular pathology-
dc.subject.keywordNeoplasms-
dc.subject.keywordPractice guidelines as topic-
dc.subject.keywordQuality control-
dc.contributor.alternativeNameShim, Hyo Sup-
dc.contributor.affiliatedAuthorShim, Hyo Sup-
dc.citation.volume51-
dc.citation.number3-
dc.citation.startPage191-
dc.citation.endPage204-
dc.identifier.bibliographicCitationJOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, Vol.51(3) : 191-204, 2017-
dc.identifier.rimsid48988-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.